Atai Life Total Debt

ATAI
 Stock
  

USD 3.53  0.37  11.71%   

Atai Life Sciences fundamentals help investors to digest information that contributes to Atai Life's financial success or failures. It also enables traders to predict the movement of Atai Life Stock. The fundamental analysis module provides a way to measure Atai Life's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Atai Life stock.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
  

Atai Life Total Debt Analysis

Atai Life's Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Total Debt 
 = 
Bonds 
+  
Notes 
More About Total Debt | All Equity Analysis

Current Atai Life Total Debt

    
  17.1 M  
Most of Atai Life's fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Atai Life Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Compare to competition

Based on the latest financial disclosure, Atai Life Sciences has a Total Debt of 17.1 M. This is 99.38% lower than that of the Healthcare sector and 94.73% lower than that of the Biotechnology industry. The total debt for all United States stocks is 99.68% higher than that of the company.

Atai Life Total Debt Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Atai Life's direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Atai Life could also be used in its relative valuation, which is a method of valuing Atai Life by comparing valuation metrics of similar companies.
Atai Life is currently under evaluation in total debt category among related companies.

Atai Life Institutional Holders

Institutional Holdings refers to the ownership stake in Atai Life that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Atai Life's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Atai Life's value.
Security TypeSharesValue
Zurcher Kantonalbank Zurich CantonalbankCommon Shares22 K80 K
Xtx Topco LtdCommon Shares17.8 K136 K
Woodline Partners LpCommon Shares750 K2.7 M
Woodline Partners LpCommon Shares763.9 K3.9 M
Woodline Partners LpCommon Shares838 K6.4 M
Woodline Partners LpCommon Shares750 K11.1 M
Woodline Partners LpCommon Shares791.6 K14.6 M

Atai Life Fundamentals

About Atai Life Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Atai Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Atai Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Atai Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The companys therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment of treatment-resistant depression RL-007, a cholinergic, glutamatergic, and GABA-B receptor modulator to treat cognitive impairment associated with schizophrenia DMX-1002, an oral formulation of ibogaine for treating opioid use disorder GRX-917, an oral formulation of a deuterated version of etifoxine for the generalized anxiety disorder treatment and NN-101, a novel intranasal formulation of N-acetylcysteine to treat mild traumatic brain injuries. Its therapeutic candidates also comprise VLS-01, a formulation of N,N-dimethyltryptamine for treating TRD EMP-01, an oral formulation of an 3,4-methyl enedioxy methamphetamine for the treatment of post-traumatic stress disorder RLS-01, a formulation of Salvinorin A for TRD KUR-101, an oral formulation of deuterated mitragynine to treat OUD and DMX-1001, an oral formulation of noribogaine for the treatment of OUD. The company was formerly known as Adripa Holding B.V. Atai Life Sciences N.V. was founded in 2018 and is headquartered in Berlin, Germany.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Atai Life without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Stock Tickers Now

   

Stock Tickers

Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
All  Next Launch Module

Pair Trading with Atai Life

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Atai Life position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Atai Life will appreciate offsetting losses from the drop in the long position's value.

Moving against Atai Life

-0.67NFLXNetflix TrendingPairCorr
The ability to find closely correlated positions to Atai Life could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Atai Life when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Atai Life - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Atai Life Sciences to buy it.
The correlation of Atai Life is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Atai Life moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Atai Life Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Atai Life can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Please continue to Atai Life Piotroski F Score and Atai Life Altman Z Score analysis. Note that the Atai Life Sciences information on this page should be used as a complementary analysis to other Atai Life's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Complementary Tools for Atai Life Stock analysis

When running Atai Life Sciences price analysis, check to measure Atai Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atai Life is operating at the current time. Most of Atai Life's value examination focuses on studying past and present price action to predict the probability of Atai Life's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Atai Life's price. Additionally, you may evaluate how the addition of Atai Life to your portfolios can decrease your overall portfolio volatility.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Is Atai Life's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Atai Life. If investors know Atai Life will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Atai Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
(0.97) 
Market Capitalization
524.2 M
Quarterly Revenue Growth YOY
(0.91) 
Return On Assets
(0.22) 
Return On Equity
(0.54) 
The market value of Atai Life Sciences is measured differently than its book value, which is the value of Atai Life that is recorded on the company's balance sheet. Investors also form their own opinion of Atai Life's value that differs from its market value or its book value, called intrinsic value, which is Atai Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Atai Life's market value can be influenced by many factors that don't directly affect Atai Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Atai Life's value and its price as these two are different measures arrived at by different means. Investors typically determine Atai Life value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Atai Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.